Aug 13, 2025 13:00
DWTX - Dogwood Therapeutics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 6.08 0.02 (0.33%) | --- | --- | --- | --- | 0.02 (0.33%) | --- | --- |
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -8.45
- Diluted EPS:
- -8.45
- Basic P/E:
- -0.7219
- Diluted P/E:
- -0.7219
- RSI(14) 1m:
- 100.0
- VWAP:
- 6.08
- RVol:
- 0.019
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price decrease 1m | 5.9 -0.08 (-1.34%) | Oct 15 12:38 |
| 1m | Price decrease 1m | 5.95 -0.1 (-1.65%) | Oct 15 12:25 |
| 10m | Price decrease 10m | 5.95 -0.22 (-3.56%) | Oct 15 12:25 |
Related News
Apr 09, 2025 17:00